The idea of quality care for rheumatoid arthritis (RA) often varies among the patient, clinician, and healthcare provider. However, there is a lack of representation of the patient’s perspective involved in the quality indicators that are the current standards for RA outcomes.
The idea of quality care for rheumatoid arthritis (RA) often varies among the patient, clinician, and healthcare provider. However, there is a lack of representation of the patient’s perspective involved in the quality indicators that are the current standards for RA outcomes.
A study published by Rheumatic & Musculoskeletal Diseases utilized a focus group and an online survey of patients with RA to gather data that represented their perspective of their care. The 6 patients included in the phase 1 focus group were asked for their positive and negative experiences involving their rheumatology care.
Participants also ranked 3 elements that they considered most important for their care, and were separated into smaller groups based on their answers. This was completed with a vote by the entire group to determine the most important domains.
The remaining domains were presented to 1132 patients with RA for the phase 2 survey. The patients were instructed to score the domains based on their importance while prioritizing 5 specific domains as the most important in rheumatology care.
The top 5 domains to evaluate the quality of care from the patient’s perspective, following the survey and focus group, were determined to be:
The researchers acknowledged that these top 5 domains are all process measures, while providers often hold a greater value on the outcome. This implies that patient satisfaction relies less heavily on the actual outcome of their care than the process to that point.
“Although the current opinion has shifted from process measurement towards outcome measurement, recent insights again highlight the importance of process indicators that are pivotal to change outcomes,” the authors wrote. “Since process measures are easier to identify and change, they have been suggested to be more appropriate for quality improvement than outcome measures.”
The researchers were able to narrow the patient perspective to a set of 5 key processes that are important in rheumatology care. Future research is necessary to further capture the patient perspective through a questionnaire for use in quality registries.
Solving the Transition Conundrum as More Children With Muscular Dystrophy Live to Adulthood
March 17th 2025Learning from examples like congenital heart disease and cystic fibrosis can help health systems and clinicians prepare to care for an influx of patients with neuromuscular diseases as they reach adulthood thanks to transformative therapy advances.
Read More
FDA Approves Expanded Indication of Eculizumab for Pediatric Generalized Myasthenia Gravis
March 15th 2025The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the indication to include pediatric patients who are 6 years or older and positive for antiacetylcholine receptor antibodies.
Read More
Technology Takes Center Stage at the 2025 AAD Annual Meeting
March 14th 2025The role of artificial intelligence, DataDerm, and telehealth in advancing dermatology care was discussed throughout the meeting, with experts highlighting their potential regarding patient access and health equity.
Read More